查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1760573

2025年介入性肿瘤消融市场报告

Interventional Tumor Ablation Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

介入性肿瘤消融市场规模预计将在未来几年强劲成长。 2029年，该市场规模将成长至24.9亿美元，复合年增长率为8.6%。预测期内的成长可归因于软组织肿瘤和转移性肿瘤发生率的上升、对个人化癌症治疗策略的日益关注、对非手术肿瘤治疗方案的需求不断增长、转向经济高效的肿瘤治疗方案，以及先进消融设备产品线的不断拓展。预测期内预计的主要趋势包括联合治疗的开发、混合烧灼术技术的研发、消融与数据分析的整合、肿瘤特异性奈米消融的创新以及消融系统技术的进步。

预计癌症盛行率的上升将在不久的将来显着推动介入性肿瘤消融市场的成长。癌症是一组由体内异常细胞不受控制的生长和扩散所定义的疾病，这些细胞可侵入周围组织并透过血液和淋巴系统转移。癌症患者数量的增加主要是由于生活方式和环境因素，例如吸烟、不良饮食、肥胖和接触致癌物质。介入性肿瘤消融透过提供微创技术改善了癌症治疗，为患者提供了手术的替代方案。这些方法透过精确破坏肿瘤来缩短治疗和恢復期，改善患者的预后和整体生活品质。例如，根据澳洲健康与福利研究所 2024 年 7 月的报告，预计到 2022 年澳洲的癌症诊断数量将增加到 160,570 例，比 2021 年的 156,781 例增加 3,789 例。癌症发生率的增加正在推动介入性肿瘤消融市场的扩张。

介入性肿瘤消融市场的主要企业正专注于开发先进的技术解决方案，例如 BioTrace 软体套件，以提高肿瘤切除术的准确性和有效性。 BioTrace 软体套件是一个整合工具，旨在追踪、管理和分析生物数据，尤其是在医疗保健和研究环境中。例如，2024 年 7 月，以色列医疗设备 Technologies Ltd. 推出了 BioTraceIO Vision 和 BioTraceIO Precision 软体套件，旨在增强影像导引的肝肿瘤消融治疗。 BioTraceIO Vision 结合人工智慧 (AI) 驱动的工具进行个人化治疗计划和评估，以提高使用标准医学影像的肝肿瘤消融程序的准确性和效率。同时，BioTraceIO Precision 在手术期间和手术后提供基于超音波的即时消融区域可视化和预测映射，帮助临床医生评估组织损伤和治疗结果，并与消融后 24 小时的电脑断层扫描高度相关。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球介入性肿瘤消融：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素及限制因素）
  • 最终用途产业分析
  • 全球介入性肿瘤消融市场：成长率分析
  • 全球介入性肿瘤消融市场表现：规模与成长，2019-2024
  • 全球介入性肿瘤消融市场预测：规模与成长，2024-2029，2034
  • 全球介入性肿瘤消融：总目标市场（TAM）

第六章市场区隔

  • 全球介入性肿瘤消融市场（依手术类型、绩效及预测）2019-2024、2024-2029、2034
  • 开放性手术
  • 微创手术
  • 影像引导干预
  • 全球介入性肿瘤消融市场（依技术、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 射频消融术（RFA）
  • 微波消融（MWA）
  • 冷冻疗法
  • 雷射消熔
  • 高强度聚焦超音波（HIFU）
  • 全球介入性肿瘤消融市场（依设备类型、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 消融系统
  • 耗材
  • 支援的设备
  • 影像系统
  • 全球介入性肿瘤消融市场的应用、绩效及预测（2019-2024、2024-2029、2034）
  • 肝臟肿瘤
  • 肾臟肿瘤
  • 肺肿瘤
  • 骨肿瘤
  • 全球介入性肿瘤消融市场（依最终用户、绩效及预测）2019-2024、2024-2029、2034
  • 医院
  • 专门癌症治疗中心
  • 门诊手术中心
  • 研究所
  • 全球介入性肿瘤消融市场，依开放性手术类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 腹腔镜肿瘤消融术
  • 开放性肿瘤切除术
  • 全球介入性肿瘤消融市场，依微创手术类型细分，绩效及预测，2019-2024年，2024-2029年，2034年
  • 经皮肿瘤消融术
  • 内视镜消融术
  • 全球介入性肿瘤消融市场，依影像导引介入类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • CT引导下肿瘤消融
  • 磁振造影引导肿瘤消融
  • 超音波引导下肿瘤消融

第七章 区域和国家分析

  • 全球介入性肿瘤消融市场各地区、绩效及预测（2019-2024、2024-2029、2034）
  • 全球介入性肿瘤消融市场（依国家/地区、绩效及预测）2019-2024、2024-2029、2034

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 介入性肿瘤消融市场：竞争格局
  • 介入性肿瘤消融市场：公司简介
    • Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
    • EDAP TMS SA Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Boston Scientific Corporation
  • Olympus Corporation
  • Terumo Corporation
  • Hologic Inc.
  • Elekta
  • Conmed Corporation
  • Bioventus Inc.
  • AtriCure
  • AngioDynamics Inc.
  • Mermaid Medical Group A/S
  • InSightec
  • Cascination AG
  • HS Hospital Service SpA
  • Theraclion
  • IceCure Medical Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年介入性肿瘤消融市场：提供新机会的国家
  • 2029年介入性肿瘤消融市场：细分领域带来新机会
  • 2029年介入性肿瘤消融市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r35450

Interventional tumor ablation is a minimally invasive procedure that utilizes image-guided techniques to target and destroy cancerous or benign tumors without the need for open surgery. It uses thermal or non-thermal energy to eliminate tumor cells while minimizing damage to surrounding healthy tissue. This procedure is often employed when surgery is not viable or as an alternative to traditional treatments.

The main product types in interventional tumor ablation include open surgery, minimally invasive surgery, and image-guided interventions. Open surgery involves making an incision in the body to access and treat the affected area, typically using scalpels and other instruments. Key technologies in this field include radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, laser ablation, and high-intensity focused ultrasound (HIFU). Device types used in these procedures include ablation systems, consumables, support devices, and imaging systems. Tumor ablation is frequently applied to liver, kidney, lung, and bone tumors. The end users of these technologies range from hospitals and specialized cancer treatment centers to ambulatory surgical centers and research institutes.

The interventional tumor ablation market research report is one of a series of new reports from The Business Research Company that provides interventional tumor ablation market statistics, including the interventional tumor ablation industry's global market size, regional shares, competitors with the interventional tumor ablation market share, detailed interventional tumor ablation market segments, market trends and opportunities, and any further data you may need to thrive in the interventional tumor ablation market. This interventional tumor ablation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The interventional tumor ablation market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.79 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period can be attributed to the increasing prevalence of liver and kidney cancers, greater awareness of minimally invasive cancer treatments, enhanced availability of diagnostic imaging, a growing geriatric population more susceptible to tumors, and a rising preference for outpatient procedures.

The interventional tumor ablation market size is expected to see strong growth in the next few years. It will grow to $2.49 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth during the forecast period can be attributed to the rising incidence of soft tissue and metastatic tumors, an increasing focus on personalized cancer treatment strategies, growing demand for non-surgical tumor treatment options, a shift toward cost-effective tumor therapies, and an expanding pipeline of advanced ablation devices. Key trends expected in the forecast period include the development of combination therapies, the creation of hybrid ablation techniques, the integration of ablation with data analytics, innovations in tumor-specific nano-ablation, and advancements in ablation system technologies.

The increasing prevalence of cancer is expected to significantly boost the growth of the interventional tumor ablation market in the near future. Cancer, a group of diseases defined by the uncontrolled proliferation and spread of abnormal cells in the body, can invade surrounding tissues and potentially metastasize through the blood and lymphatic systems. The growing number of cancer cases is largely attributed to lifestyle and environmental factors such as smoking, poor diet, obesity, and exposure to carcinogens. Interventional tumor ablation improves cancer treatment by offering minimally invasive techniques, providing patients with an alternative to surgery. These methods shorten treatment time and recovery periods by allowing precise destruction of tumors, which improves patient outcomes and overall quality of life. For example, according to a July 2024 report from the Australian Institute of Health and Welfare, the number of cancer diagnoses in Australia increased to 160,570 in 2022, marking a rise of 3,789 cases from 156,781 in 2021. This growing cancer incidence is driving the expansion of the interventional tumor ablation market.

Leading companies in the interventional tumor ablation market are focusing on developing advanced technological solutions, such as the BioTrace software suite, to improve the precision and effectiveness of tumor ablation procedures. BioTrace software suites are integrated tools designed to track, manage, and analyze biological data, particularly in healthcare and research environments. For example, in July 2024, TechsoMed Medical Technologies Ltd., an Israel-based medical device company, introduced the BioTraceIO Vision and BioTraceIO Precision software suites, aimed at enhancing image-guided liver tumor ablation therapy. BioTraceIO Vision incorporates artificial intelligence (AI)-powered tools for personalized treatment planning and assessment, using standard medical imaging to boost the accuracy and efficiency of liver tumor ablation procedures. BioTraceIO Precision, on the other hand, provides real-time ultrasound-based visualization and predictive mapping of the ablation zone during and after the procedure, helping clinicians evaluate tissue damage and treatment outcomes with high correlation to 24-hour post-ablation CT scans.

In February 2024, Immunophotonics Inc., a US-based biotechnology company, formed a partnership with AngioDynamics Inc. This collaboration aims to combine Immunophotonics' leading immunotherapy asset, IP-001, with AngioDynamics' ablation devices to explore the potential of combining ablation with immunotherapy in treating solid tumor cancers. AngioDynamics Inc., a US-based medical device company, offers microwave and radiofrequency ablation technologies for minimally invasive cancer treatment.

Major players in the interventional tumor ablation market are Johnson And Johnson, EDAP TMS S.A., Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Hologic Inc., Elekta, Conmed Corporation, Bioventus Inc., AtriCure, AngioDynamics Inc., Mermaid Medical Group A/S, InSightec, Cascination AG, H.S. Hospital Service S.p.A, Theraclion, IceCure Medical Ltd.

North America was the largest region in the interventional tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interventional tumor ablation report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the interventional tumor ablation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The interventional tumor ablation market consists of revenues earned by entities by providing services such as electroporation, tumor biopsy services, thermal ablation monitoring, and post-ablation follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional tumor ablation market also includes sales of radiofrequency ablation (RFA) generators, microwave ablation (MWA) systems, cryoablation probes, laser fibers and electrode needles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Tumor Ablation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional tumor ablation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional tumor ablation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional tumor ablation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Procedure Type: Open Surgery; Minimally Invasive Surgery; Image-Guided Interventions
  • 2) By Technology: Radiofrequency Ablation (RFA); Microwave Ablation (MWA); Cryoablation; Laser Ablation; High-Intensity Focused Ultrasound (HIFU)
  • 3) By Device Type: Ablation Systems; Consumables; Support Devices; Imaging Systems
  • 4) By Application Area: Liver Tumors; Kidney Tumors; Lung Tumors; Bone Tumors
  • 5) By End User: Hospitals; Specialized Cancer Treatment Centers; Ambulatory Surgical Centers; Research Institutes
  • Subsegments:
  • 1) By Open Surgery: Laparoscopic Tumor Ablation; Thoracotomy Tumor Ablation
  • 2) By Minimally Invasive Surgery: Percutaneous Tumor Ablation; Endoscopic Ablation
  • 3) By Image-Guided Interventions: Computed Tomography-Guided Tumor Ablation; Magnetic Resonance Imaging-Guided Tumor Ablation; Ultrasound-Guided Tumor Ablation
  • Companies Mentioned: Johnson And Johnson; EDAP TMS S.A.; Medtronic plc; Siemens Healthineers AG; Stryker Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Tumor Ablation Market Characteristics

3. Interventional Tumor Ablation Market Trends And Strategies

4. Interventional Tumor Ablation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Interventional Tumor Ablation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Interventional Tumor Ablation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Interventional Tumor Ablation Market Growth Rate Analysis
  • 5.4. Global Interventional Tumor Ablation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Interventional Tumor Ablation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Interventional Tumor Ablation Total Addressable Market (TAM)

6. Interventional Tumor Ablation Market Segmentation

  • 6.1. Global Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Open Surgery
  • Minimally Invasive Surgery
  • Image-Guided Interventions
  • 6.2. Global Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation (RFA)
  • Microwave Ablation (MWA)
  • Cryoablation
  • Laser Ablation
  • High-Intensity Focused Ultrasound (HIFU)
  • 6.3. Global Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ablation Systems
  • Consumables
  • Support Devices
  • Imaging Systems
  • 6.4. Global Interventional Tumor Ablation Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liver Tumors
  • Kidney Tumors
  • Lung Tumors
  • Bone Tumors
  • 6.5. Global Interventional Tumor Ablation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialized Cancer Treatment Centers
  • Ambulatory Surgical Centers
  • Research Institutes
  • 6.6. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Open Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laparoscopic Tumor Ablation
  • Thoracotomy Tumor Ablation
  • 6.7. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Minimally Invasive Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Percutaneous Tumor Ablation
  • Endoscopic Ablation
  • 6.8. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Image-Guided Interventions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Computed Tomography-Guided Tumor Ablation
  • Magnetic Resonance Imaging-Guided Tumor Ablation
  • Ultrasound-Guided Tumor Ablation

7. Interventional Tumor Ablation Market Regional And Country Analysis

  • 7.1. Global Interventional Tumor Ablation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Interventional Tumor Ablation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Interventional Tumor Ablation Market

  • 8.1. Asia-Pacific Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Interventional Tumor Ablation Market

  • 9.1. China Interventional Tumor Ablation Market Overview
  • 9.2. China Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Interventional Tumor Ablation Market

  • 10.1. India Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Interventional Tumor Ablation Market

  • 11.1. Japan Interventional Tumor Ablation Market Overview
  • 11.2. Japan Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Interventional Tumor Ablation Market

  • 12.1. Australia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Interventional Tumor Ablation Market

  • 13.1. Indonesia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Interventional Tumor Ablation Market

  • 14.1. South Korea Interventional Tumor Ablation Market Overview
  • 14.2. South Korea Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Interventional Tumor Ablation Market

  • 15.1. Western Europe Interventional Tumor Ablation Market Overview
  • 15.2. Western Europe Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Interventional Tumor Ablation Market

  • 16.1. UK Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Interventional Tumor Ablation Market

  • 17.1. Germany Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Interventional Tumor Ablation Market

  • 18.1. France Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Interventional Tumor Ablation Market

  • 19.1. Italy Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Interventional Tumor Ablation Market

  • 20.1. Spain Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Interventional Tumor Ablation Market

  • 21.1. Eastern Europe Interventional Tumor Ablation Market Overview
  • 21.2. Eastern Europe Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Interventional Tumor Ablation Market

  • 22.1. Russia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Interventional Tumor Ablation Market

  • 23.1. North America Interventional Tumor Ablation Market Overview
  • 23.2. North America Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Interventional Tumor Ablation Market

  • 24.1. USA Interventional Tumor Ablation Market Overview
  • 24.2. USA Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Interventional Tumor Ablation Market

  • 25.1. Canada Interventional Tumor Ablation Market Overview
  • 25.2. Canada Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Interventional Tumor Ablation Market

  • 26.1. South America Interventional Tumor Ablation Market Overview
  • 26.2. South America Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Interventional Tumor Ablation Market

  • 27.1. Brazil Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Interventional Tumor Ablation Market

  • 28.1. Middle East Interventional Tumor Ablation Market Overview
  • 28.2. Middle East Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Interventional Tumor Ablation Market

  • 29.1. Africa Interventional Tumor Ablation Market Overview
  • 29.2. Africa Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Interventional Tumor Ablation Market Competitive Landscape And Company Profiles

  • 30.1. Interventional Tumor Ablation Market Competitive Landscape
  • 30.2. Interventional Tumor Ablation Market Company Profiles
    • 30.2.1. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. EDAP TMS S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Interventional Tumor Ablation Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Olympus Corporation
  • 31.3. Terumo Corporation
  • 31.4. Hologic Inc.
  • 31.5. Elekta
  • 31.6. Conmed Corporation
  • 31.7. Bioventus Inc.
  • 31.8. AtriCure
  • 31.9. AngioDynamics Inc.
  • 31.10. Mermaid Medical Group A/S
  • 31.11. InSightec
  • 31.12. Cascination AG
  • 31.13. H.S. Hospital Service S.p.A
  • 31.14. Theraclion
  • 31.15. IceCure Medical Ltd.

32. Global Interventional Tumor Ablation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Tumor Ablation Market

34. Recent Developments In The Interventional Tumor Ablation Market

35. Interventional Tumor Ablation Market High Potential Countries, Segments and Strategies

  • 35.1 Interventional Tumor Ablation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Interventional Tumor Ablation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Interventional Tumor Ablation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer